The mission will give Israel access to a large population in which to test four promising approaches to rapid diagnosis of SARS-CoV-2 coronavirus.
Israeli researchers are developing faster, more accurate ways to test people for the SARS-CoV-2 coronavirus. But due to Israel’s small population, clinical trials to validate efficacy take a lot of time.
On July 26, the Israeli Defense, Foreign Affairs and Health ministries sent a delegation to India, led by the Defense Ministry’s Directorate of Defense Research and Development (DDR&D), to determine the effectiveness of four promising rapid diagnostic solutions.
“Since the start of the pandemic, the DDR&D has tested dozens of diagnostic technologies. Some of them have matured and passed initial trials in Israel. However, in order to complete testing and prove their effectiveness, these must be tested on a wide range of patients,” the ministry explained in a press statement.
“The cooperation between Israel and India will enable the delegation and its Indian counterparts to collect tens of thousands of samples in just 10 days, and analyze them using computer systems based on artificial intelligence. This massive sampling will shorten processes and advance the approval of effective technology. All tests will be validated using PCR tests.”
India has designated a local team of around 100 professionals, as well as a team to construct testing sites that will be operated jointly by the Israeli and Indian delegations.
…Among the four developments to be tested is the Naor isothermal test that detects the virus in a heated saliva sample within 30 minutes, being developed by Rapid Diagnostic Systems.
“This operation conveys a message of friendship and solidarity with India. It also provides a unique opportunity for scientific and technological cooperation that can assist Israel, India and the world in coping both with the pandemic and with the economic crisis that came with it,” said Foreign Minister Gabi Ashkenazi.